BehaveNet^® Clinical Capsule™:

drug: dantrolene

Clinical class	treatment of Neuroleptic Malignant Syndrome; antispastic, muscle relaxant
Action	blocks release of Ca from sarcoplasmic reticulum
Chemical class	hydantoin derivative
CSA schedule	none
DEA number	none
Routes of administration	oral, intravenous
Associated with (substance-related)	disorders: none
Availability	prescription

Dantrium^®,Dantrium^® IV (P & G Pharmaceuticals) FDA approved for treatment of : chronic spasticity, malignant hyperthermia